Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.
2007 ◽
Vol 25
(4)
◽
pp. 359-360
2006 ◽
Vol 66
(18)
◽
pp. 9134-9142
◽
2011 ◽
Vol 27
(5)
◽
pp. 565-574
◽
2007 ◽
Vol 1770
(9)
◽
pp. 1369-1373
◽
2007 ◽
Vol 69
(3)
◽
pp. 204-211
◽
2008 ◽
Vol 14
(22)
◽
pp. 7272-7283
◽
2001 ◽
Vol 16
(5)
◽
pp. 359-370
◽
2015 ◽
pp. 49-65
◽
2006 ◽
Vol 16
(5)
◽
pp. 713-718
◽